UNSPSC 51143402: Acetaminophen/dichloralphenazone/isometheptene

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class CN105. This VA Drug Class (CN105) classifies this compound as belonging to the group ANTIMIGRAINE AGENTS.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51143402 Acetaminophen/dichloralphenazone/isometheptene is a Commodity code that captures pharmaceutical products and over-the-counter medications, though recent state and local procurement activity under this code shows minimal relevant volume. The single recent opportunity identified does not align with the code's nominal scope: Seminole County, Florida posted an IFB (IFB60459723LAS) in June 2026 for naloxone and drug deactivation systems, which are controlled substances and medical devices rather than the analgesic combination products the code describes. State and local governments buy medications, pain relievers, and related pharmaceutical supplies under this tier, but the recent posting volume under this specific code does not support characterization of active issuing-body patterns or market concentration.

The mismatch between code assignment and actual procurement suggests either a tagging error in the county's e-Procurement system or a miscoding in the underlying opportunity feed. Seminole County's naloxone solicitation, which carries a response deadline of July 26, 2023, reflects community health and emergency-response purchasing rather than routine pharmaceutical procurement. Without additional opportunities posted under 51143402 in the recent period, the code presents limited signal for business development targeting. Practitioners pursuing pharmaceutical or OTC medication sales to state and local health agencies should monitor related Family-level pharmacy and medical supply codes for more consistent activity.